Plea over NAT in blood banks: Why should we pretend we know medical science, says SC

The Supreme Court of India raised critical questions regarding the use of Nucleic Acid Testing (NAT) in blood banks during a recent hearing on a plea advocating for its mandatory implementation. The court expressed skepticism about the legal system's ability to navigate complex medical science, emphasizing that judicial bodies should not presume expertise in fields beyond their purview. The plea highlighted the significance of NAT in enhancing blood safety by detecting viral infections, including HIV and Hepatitis, much earlier than traditional testing methods. The court's remarks underscore a broader issue concerning the intersection of law and healthcare, particularly in ensuring that medical practices keep pace with advancements in technology. As India continues to grapple with public health challenges, the discussion around NAT could lead to pivotal changes in blood safety protocols, aiming to protect patients and improve overall health outcomes across the nation.